Todd M. Herrington
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Todd M. Herrington has a total of 170 co-authors. Here are the top co-authors by number of shared publications:
Andrea A. Kühn
Charité - University Medicine Berlin, Department of Neurology, Movement Disorders and Neuromodulation Unit, Berlin, Germany
3 shared publications- Andreas Horn
Center for Neurotechnology and Neurorecovery, Department of Neurology, Massachusetts General Hospital and Harvard Medical School
3 shared publications - Ningfei Li
Charité Universitaetsmedizin Berlin
3 shared publications - Daniel Gerard Dillon
Center for Depression, Anxiety, and Stress Research, McLean Hospital, Belmont, MA, USA
2 shared publications - David C. Steinberger
Center for Depression, Anxiety, and Stress Research, McLean Hospital, Belmont, MA, USA
2 shared publications - Diego A. Pizzagalli
Noel Drury, M.D. Institute for Translational Depression Discoveries, University of California, Irvine, USA
2 shared publications
Latest Publications
- Open Access
Acute stress reorganizes pregenual cingulate and subthalamic coupling to approach-avoidance decisions in remitted depression
Major depressive disorder (MDD) is highly recurrent, and psychosocial stress is a central precipitant of relapses. Daily choices require weighing potential rewards against costs, a process disrupted in MDD that may contribute to relapse. Here, we tested whether a psychosocial stressor affects neural and computational mechanisms underlying approach-avoidance decision making in individuals with remitted MDD (rMDD, N=50) and healthy controls (N=74), prioritizing pregenual anterior cingulate cortex (pgACC) and subthalamic nucleus (STN) due to their roles in value integration and decision caution, respectively. Participants performed a dynamic approach-avoidance conflict task with fMRI before and after psychosocial stress. Hierarchical Bayesian drift-diffusion modeling evaluated whether stress modulated computational and neural mechanisms, with trial-wise pgACC and STN activity entered as neural regressors on evidence accumulation and decision threshold, respectively. Before stress, groups did not differ in any decision parameter, but pgACC activity contributed to evidence accumulation toward avoidance in controls only. After stress, rMDD showed larger increases than controls in the impact of both reward and aversiveness on accumulation toward approach and avoidance, respectively, predominantly for net-aversive offers. Furthermore, in rMDD, stress rendered both approach and avoidance decisions more sensitive to pgACC activity, and STN activity was more strongly coupled to the decision threshold than in controls. Finally, stress-induced increases in reward sensitivity in rMDD predicted one-year course of depressive symptoms. Thus, MDD remission is not characterized by a generalized blunting of decision-making, but by a latent circuit difference that acute stress reorganizes and predicts future symptoms.
Open AccessAcute stress reorganizes pregenual cingulate and subthalamic coupling to approach-avoidance decisions in remitted depression
Major depressive disorder (MDD) is highly recurrent, and psychosocial stress is a central precipitant of relapses. Daily choices require weighing potential rewards against costs, a process disrupted in MDD that may contribute to relapse. Here, we tested whether a psychosocial stressor affects neural and computational mechanisms underlying approach-avoidance decision making in individuals with remitted MDD (rMDD, N=50) and healthy controls (N=74), prioritizing pregenual anterior cingulate cortex (pgACC) and subthalamic nucleus (STN) due to their roles in value integration and decision caution, respectively. Participants performed a dynamic approach-avoidance conflict task with fMRI before and after psychosocial stress. Hierarchical Bayesian drift-diffusion modeling evaluated whether stress modulated computational and neural mechanisms, with trial-wise pgACC and STN activity entered as neural regressors on evidence accumulation and decision threshold, respectively. Before stress, groups did not differ in any decision parameter, but pgACC activity contributed to evidence accumulation toward avoidance in controls only. After stress, rMDD showed larger increases than controls in the impact of both reward and aversiveness on accumulation toward approach and avoidance, respectively, predominantly for net-aversive offers. Furthermore, in rMDD, stress rendered both approach and avoidance decisions more sensitive to pgACC activity, and STN activity was more strongly coupled to the decision threshold than in controls. Finally, stress-induced increases in reward sensitivity in rMDD predicted one-year course of depressive symptoms. Thus, MDD remission is not characterized by a generalized blunting of decision-making, but by a latent circuit difference that acute stress reorganizes and predicts future symptoms.
- Open Access
- 5 October 2026
- Published by Wiley in Movement Disorders
Directional Adaptive Deep Brain Stimulation: An Initial Report of Safety, Tolerability, and Effectiveness
Background: Adaptive deep brain stimulation (aDBS) is a safe and effective therapy for people with Parkinson's disease (PWP). Utilization of directional aDBS has not been specifically evaluated. Objectives: The goal is to report the first data on the safety, tolerability, and preliminary effectiveness of chronic, directional aDBS in PWP. Methods: A supplemental cohort from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease Trial received directional aDBS. Participants who were previously receiving stable continuous directional DBS (dDBS) completed an open‐label evaluation of two aDBS modes. Results: Seventeen participants were enrolled, with 15 completing directional aDBS evaluation. The prespecified primary endpoint and post hoc success criterion was met for both directional aDBS modes. On‐time without troublesome dyskinesia was increased, with a median of 1.2 hours/day in directional dual threshold aDBS mode. Stimulation‐related events were similar between dDBS and directional aDBS. All 15 participants chose to continue with directional aDBS chronically. Conclusions: Preliminary data indicates chronic directional aDBS is feasible, tolerable, effective, and safe in PWP. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 5 October 2026
- Published by Wiley in Movement Disorders
Open AccessDirectional Adaptive Deep Brain Stimulation: An Initial Report of Safety, Tolerability, and Effectiveness
Background: Adaptive deep brain stimulation (aDBS) is a safe and effective therapy for people with Parkinson's disease (PWP). Utilization of directional aDBS has not been specifically evaluated. Objectives: The goal is to report the first data on the safety, tolerability, and preliminary effectiveness of chronic, directional aDBS in PWP. Methods: A supplemental cohort from the Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease Trial received directional aDBS. Participants who were previously receiving stable continuous directional DBS (dDBS) completed an open‐label evaluation of two aDBS modes. Results: Seventeen participants were enrolled, with 15 completing directional aDBS evaluation. The prespecified primary endpoint and post hoc success criterion was met for both directional aDBS modes. On‐time without troublesome dyskinesia was increased, with a median of 1.2 hours/day in directional dual threshold aDBS mode. Stimulation‐related events were similar between dDBS and directional aDBS. All 15 participants chose to continue with directional aDBS chronically. Conclusions: Preliminary data indicates chronic directional aDBS is feasible, tolerable, effective, and safe in PWP. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 5 October 2026
- Published by Wiley in Movement Disorders Clinical Practice
Microelectrode Recording in DBS Surgery: An Educational Resource
Microelectrode recording (MER) is a technique used during deep brain stimulation (DBS) surgery to guide electrode placement. After a stereotactic trajectory has been planned based on pre‐ and intraoperative imaging, a microelectrode capable of recording extracellular action potentials is inserted along the planned DBS electrode trajectory. By recognizing the characteristic features of the target structures, the intraoperative neurophysiologist and neurosurgeon work together to confirm that the trajectory is appropriate.
- 5 October 2026
- Published by Wiley in Movement Disorders Clinical Practice
Microelectrode Recording in DBS Surgery: An Educational Resource
Microelectrode recording (MER) is a technique used during deep brain stimulation (DBS) surgery to guide electrode placement. After a stereotactic trajectory has been planned based on pre‐ and intraoperative imaging, a microelectrode capable of recording extracellular action potentials is inserted along the planned DBS electrode trajectory. By recognizing the characteristic features of the target structures, the intraoperative neurophysiologist and neurosurgeon work together to confirm that the trajectory is appropriate.
- Open Access
- 3 August 2026
- Published by Wiley in Movement Disorders
A Gap Analysis of Deep Brain Stimulation for Childhood‐Onset Movement Disorders
Background: Deep brain stimulation (DBS) is an established and increasingly utilized therapy for childhood‐onset movement disorders. However, pediatric DBS poses unique challenges that are not adequately addressed by adult‐derived paradigms. Objective: To identify key gaps in the current use of DBS in childhood‐onset movement disorders and to highlight emerging pediatric‐specific strategies across the care pathway, including patient selection, targeting, surgical approaches, programming, and outcome assessment. Methods: This educational review represents the opinions of seven clinicians and clinical researchers with extensive experience in pediatric DBS and was informed by a focused literature review of key domains identified by the authors as current gaps in the field. Conclusions: Despite substantial progress, important gaps persist across multiple domains of pediatric DBS, including the lack of standardized, pediatric‐specific selection frameworks, limited biomarkers to guide therapy, challenges in defining meaningful outcomes, and significant global disparities in access. Emerging approaches, including individualized and genotype‐informed strategies, advances in neuromodulation technology, and international collaboration, offer potential pathways to address these limitations. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- 3 August 2026
- Published by Wiley in Movement Disorders
Open AccessA Gap Analysis of Deep Brain Stimulation for Childhood‐Onset Movement Disorders
Background: Deep brain stimulation (DBS) is an established and increasingly utilized therapy for childhood‐onset movement disorders. However, pediatric DBS poses unique challenges that are not adequately addressed by adult‐derived paradigms. Objective: To identify key gaps in the current use of DBS in childhood‐onset movement disorders and to highlight emerging pediatric‐specific strategies across the care pathway, including patient selection, targeting, surgical approaches, programming, and outcome assessment. Methods: This educational review represents the opinions of seven clinicians and clinical researchers with extensive experience in pediatric DBS and was informed by a focused literature review of key domains identified by the authors as current gaps in the field. Conclusions: Despite substantial progress, important gaps persist across multiple domains of pediatric DBS, including the lack of standardized, pediatric‐specific selection frameworks, limited biomarkers to guide therapy, challenges in defining meaningful outcomes, and significant global disparities in access. Emerging approaches, including individualized and genotype‐informed strategies, advances in neuromodulation technology, and international collaboration, offer potential pathways to address these limitations. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
- Open Access
Independent Basal Ganglia Neural Populations Encode Speech Production and Ambient-Noise Levels
The function of the basal ganglia (BG), a set of nuclei deep in the brain, is still under debate despite their clinical relevance. Lines of evidence from non-human primate and human experiments suggest that one key causal contribution of the adult primate BG is invigoration of movement according to environmental and energetic constraints. Previous studies have come to this conclusion using primarily limb motor control tasks. We hypothesized BG are also important for invigorating the respiratory, vocal, and articulatory motor systems during speech production. To test this, we used a rare clinical opportunity to record local field potentials-broadband gamma activity (LFP-BGA) and single unit (SU) activity from human basal ganglia during deep brain stimulation implant surgeries. Participants repeated sentences aloud in the operating room. We modulated environmental and energetic constraints of speech production by inducing the Lombard Effect, wherein people reliably increase the intensity of their voice in the presence of background noise. Participants increased voice intensity, pitch, vowel space size, and respiratory depth in the presence of ambient noise. ∼40% of LFP and SU sites were modulated by speech production. Comparing globus pallidus (GP) LFP-BGA, herein reported for the first time during speech, to subthalamic nucleus (STN) LFP-BGA revealed GP activated after STN. STN was more coincident with the speech preparatory period and GP more coincident with speech onset, suggesting differential roles in speech production. We found only weak evidence that STN or GP activity encodes the level of produced speech intensity. Instead, we found that LFP-BGA and SU-FR robustly track the ambient background noise levels. Linear decoding from SU-firing rate revealed we could infer the background noise levels with >75% accuracy in any given time point in the trial, including baseline. Importantly, the ambient-noise-modulated sites were an independent population from speech-modulated sites. We conclude that human BG encode the energetic constraints of communication. We theorize that the code is leveraged in downstream BG-cortical loop nodes to invigorate speech oro-motor gestures and co-speech manual limb gestures, both of which respond to ambient noise levels to maintain high-fidelity communication.
Open AccessIndependent Basal Ganglia Neural Populations Encode Speech Production and Ambient-Noise Levels
The function of the basal ganglia (BG), a set of nuclei deep in the brain, is still under debate despite their clinical relevance. Lines of evidence from non-human primate and human experiments suggest that one key causal contribution of the adult primate BG is invigoration of movement according to environmental and energetic constraints. Previous studies have come to this conclusion using primarily limb motor control tasks. We hypothesized BG are also important for invigorating the respiratory, vocal, and articulatory motor systems during speech production. To test this, we used a rare clinical opportunity to record local field potentials-broadband gamma activity (LFP-BGA) and single unit (SU) activity from human basal ganglia during deep brain stimulation implant surgeries. Participants repeated sentences aloud in the operating room. We modulated environmental and energetic constraints of speech production by inducing the Lombard Effect, wherein people reliably increase the intensity of their voice in the presence of background noise. Participants increased voice intensity, pitch, vowel space size, and respiratory depth in the presence of ambient noise. ∼40% of LFP and SU sites were modulated by speech production. Comparing globus pallidus (GP) LFP-BGA, herein reported for the first time during speech, to subthalamic nucleus (STN) LFP-BGA revealed GP activated after STN. STN was more coincident with the speech preparatory period and GP more coincident with speech onset, suggesting differential roles in speech production. We found only weak evidence that STN or GP activity encodes the level of produced speech intensity. Instead, we found that LFP-BGA and SU-FR robustly track the ambient background noise levels. Linear decoding from SU-firing rate revealed we could infer the background noise levels with >75% accuracy in any given time point in the trial, including baseline. Importantly, the ambient-noise-modulated sites were an independent population from speech-modulated sites. We conclude that human BG encode the energetic constraints of communication. We theorize that the code is leveraged in downstream BG-cortical loop nodes to invigorate speech oro-motor gestures and co-speech manual limb gestures, both of which respond to ambient noise levels to maintain high-fidelity communication.
- 23 February 2024
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 9 (7) , 726-736
Cognitive Signatures of Depressive and Anhedonic Symptoms and Affective States Using Computational Modeling and Neurocognitive Testing
- 23 February 2024
- Published by Elsevier in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
- Vol. 9 (7) , 726-736
Cognitive Signatures of Depressive and Anhedonic Symptoms and Affective States Using Computational Modeling and Neurocognitive Testing
- 23 December 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 24 (5) , 524-532
Accurate Deep Brain Stimulation Lead Placement Concurrent With Research Electrocorticography
BACKGROUND: Using electrocorticography for research (R-ECoG) during deep brain stimulation (DBS) surgery has advanced our understanding of human cortical-basal ganglia neurophysiology and mechanisms of therapeutic circuit modulation. The safety of R-ECoG has been established, but potential effects of temporary ECoG strip placement on targeting accuracy have not been reported. OBJECTIVE: To determine whether temporary subdural electrode strip placement during DBS implantation surgery affects lead implantation accuracy. METHODS: Twenty-four consecutive patients enrolled in a prospective database who underwent awake DBS surgery were identified. Ten of 24 subjects participated in R-ECoG. Lead locations were determined after fusing postoperative computed tomography scans into the surgical planning software. The effect of brain shift was quantified using Lead-DBS and analyzed in a mixed-effects model controlling for time interval to postoperative computed tomography. Targeting accuracy was reported as radial and Euclidean distance errors and compared with Mann–Whitney tests. RESULTS: Neither radial error nor Euclidean distance error differed significantly between R-ECoG participants and nonparticipants. Pneumocephalus volume did not differ between the 2 groups, but brain shift was slightly greater with R-ECoG. Pneumocephalus volume correlated with brain shift, but neither of these measures significantly correlated with Euclidean distance error. There were no complications in either group. CONCLUSION: In addition to an excellent general safety profile as has been reported previously, these results suggest that performing R-ECoG during DBS implantation surgery does not affect the accuracy of lead placement.
- 23 December 2022
- Published by Wolters Kluwer Health in Operative Neurosurgery
- Vol. 24 (5) , 524-532
Accurate Deep Brain Stimulation Lead Placement Concurrent With Research Electrocorticography
BACKGROUND: Using electrocorticography for research (R-ECoG) during deep brain stimulation (DBS) surgery has advanced our understanding of human cortical-basal ganglia neurophysiology and mechanisms of therapeutic circuit modulation. The safety of R-ECoG has been established, but potential effects of temporary ECoG strip placement on targeting accuracy have not been reported. OBJECTIVE: To determine whether temporary subdural electrode strip placement during DBS implantation surgery affects lead implantation accuracy. METHODS: Twenty-four consecutive patients enrolled in a prospective database who underwent awake DBS surgery were identified. Ten of 24 subjects participated in R-ECoG. Lead locations were determined after fusing postoperative computed tomography scans into the surgical planning software. The effect of brain shift was quantified using Lead-DBS and analyzed in a mixed-effects model controlling for time interval to postoperative computed tomography. Targeting accuracy was reported as radial and Euclidean distance errors and compared with Mann–Whitney tests. RESULTS: Neither radial error nor Euclidean distance error differed significantly between R-ECoG participants and nonparticipants. Pneumocephalus volume did not differ between the 2 groups, but brain shift was slightly greater with R-ECoG. Pneumocephalus volume correlated with brain shift, but neither of these measures significantly correlated with Euclidean distance error. There were no complications in either group. CONCLUSION: In addition to an excellent general safety profile as has been reported previously, these results suggest that performing R-ECoG during DBS implantation surgery does not affect the accuracy of lead placement.
- Top Cited Papers
- 3 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (579)
Smartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease
Longitudinal, remote monitoring of motor symptoms in Parkinson’s disease (PD) could enable more precise treatment decisions. We developed the Motor fluctuations Monitor for Parkinson’s Disease (MM4PD), an ambulatory monitoring system that used smartwatch inertial sensors to continuously track fluctuations in resting tremor and dyskinesia. We designed and validated MM4PD in 343 participants with PD, including a longitudinal study of up to 6 months in a 225-subject cohort. MM4PD measurements correlated to clinical evaluations of tremor severity (ρ = 0.80) and mapped to expert ratings of dyskinesia presence (P < 0.001) during in-clinic tasks. MM4PD captured symptom changes in response to treatment that matched the clinician’s expectations in 94% of evaluated subjects. In the remaining 6% of cases, symptom data from MM4PD identified opportunities to make improvements in pharmacologic strategy. These results demonstrate the promise of MM4PD as a tool to support patient-clinician communication, medication titration, and clinical trial design.
- 3 February 2021
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 13 (579)
Top Cited PapersSmartwatch inertial sensors continuously monitor real-world motor fluctuations in Parkinson’s disease
Longitudinal, remote monitoring of motor symptoms in Parkinson’s disease (PD) could enable more precise treatment decisions. We developed the Motor fluctuations Monitor for Parkinson’s Disease (MM4PD), an ambulatory monitoring system that used smartwatch inertial sensors to continuously track fluctuations in resting tremor and dyskinesia. We designed and validated MM4PD in 343 participants with PD, including a longitudinal study of up to 6 months in a 225-subject cohort. MM4PD measurements correlated to clinical evaluations of tremor severity (ρ = 0.80) and mapped to expert ratings of dyskinesia presence (P < 0.001) during in-clinic tasks. MM4PD captured symptom changes in response to treatment that matched the clinician’s expectations in 94% of evaluated subjects. In the remaining 6% of cases, symptom data from MM4PD identified opportunities to make improvements in pharmacologic strategy. These results demonstrate the promise of MM4PD as a tool to support patient-clinician communication, medication titration, and clinical trial design.
- 20 November 2020
- Published by Wiley in Movement Disorders
- Vol. 35 (11) , 2119-2120
Toward a Personalized Approach to Parkinson's Cell Therapy
- 20 November 2020
- Published by Wiley in Movement Disorders
- Vol. 35 (11) , 2119-2120
Toward a Personalized Approach to Parkinson's Cell Therapy
- Open Access
- 1 January 2019
- Published by Elsevier in NeuroImage
- Vol. 184, 586-598
Optimization and comparative evaluation of nonlinear deformation algorithms for atlas-based segmentation of DBS target nuclei
- 1 January 2019
- Published by Elsevier in NeuroImage
- Vol. 184, 586-598
Open AccessOptimization and comparative evaluation of nonlinear deformation algorithms for atlas-based segmentation of DBS target nuclei